EHA 2015 | Treating mantle cell lymphoma earlier in the disease course

Name: Treating mantle cell lymphoma earlier in the disease course
Uploaded: 2015-06-12T00:00:00.000Z
Duration: 2 min 17 s
Description: At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the movement towards utilizing novel therapeutic agents earlier in the disease course of mantle cell lymphoma.

Marek Trněný • 12 Jun 2015

EHA 2015

Mantle Cell Lymphoma Ibrutinib Lenalidomide Rituximab

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the movement towards utilizing novel therapeutic agents earlier in the disease course of mantle cell lymphoma.